Opana ER
- Product NDC
- 63629-4174
- 11-digit product format
- 636294174
- Labeler code
- 63629
- Product ID
- 63629-4174_b0d683e0-ee2e-4a82-8ae5-fec301c8167b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- OXYMORPHONE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- NDA021610
- Marketing category
- NDA
- Marketing start
- 2010-12-31
- Marketing end
- 0000-00-00
- Substance
- OXYMORPHONE HYDROCHLORIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63629-4174-1 | 2021-11-17 | C162847 | 48780-1 | 9855d018-e68a-cd31-e053-dbdaa90ab51a | 0ae0e103-5250-4745-8ae2-74fa47fbf973 |
| 63629-4174-2 | 2021-11-17 | C162847 | 48780-1 | 9855d018-e68a-cd31-e053-dbdaa90ab51a | 0ae0e103-5250-4745-8ae2-74fa47fbf973 |
| 63629-4174-3 | 2021-11-17 | C162847 | 48780-1 | 9855d018-e68a-cd31-e053-dbdaa90ab51a | 0ae0e103-5250-4745-8ae2-74fa47fbf973 |
| 63629-4174-4 | 2021-11-17 | C162847 | 48780-1 | 9855d018-e68a-cd31-e053-dbdaa90ab51a | 0ae0e103-5250-4745-8ae2-74fa47fbf973 |
| 63629-4174-1 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e68a-cd31-e053-dbdaa90ab51a | 0ae0e103-5250-4745-8ae2-74fa47fbf973 |
| 63629-4174-2 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e68a-cd31-e053-dbdaa90ab51a | 0ae0e103-5250-4745-8ae2-74fa47fbf973 |
| 63629-4174-3 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e68a-cd31-e053-dbdaa90ab51a | 0ae0e103-5250-4745-8ae2-74fa47fbf973 |
| 63629-4174-4 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e68a-cd31-e053-dbdaa90ab51a | 0ae0e103-5250-4745-8ae2-74fa47fbf973 |